Program

Zurich, Tuesday, 12 November 2019, 17.15 - 18.45


Welcome and Introduction
Dr. Matthias Staehelin, Partner, VISCHER AG
Dr. Stefan Kohler, Partner, VISCHER AG

 

Highlights of the Recent Regulatory and Market Development in China's Life Sciences Sector
Fiona Gao, Manager of China Life Sciences Group and Associate, VISCHER AG
 

Market Introductions into China, A Practitioner's View
Wei Qu, Senior Regulatory Affairs Manager, Tigermed Co., Ltd
 

Introduction and Summary of two Business Models
Christian Wyss, Partner, VISCHER AG

  • Model 1: Equity Investment from Chinese Company and Chinese Market Collaboration
    Case Study of Vaximm and China Medical System
    Thomas Hecht, Chairman, Vaximm AG
     
  • Model 2: Establish a collaboration or joint venture with a Chinese Partner
    Brian Hashemi, Chairman, Novigenix SA
     

Summary and Closing
Dr. Matthias Staehelin, Partner, VISCHER AG
Dr. Stefan Kohler, Partner, VISCHER AG


Following the discussion, VISCHER cordially invites you to an aperitif.